Reduced zidovudine toxic metabolite formation after administration of a sustained-release zidovudine formulation

被引：0

作者：

Hollister, AS

Lantz, RK

Sulik, PL

Dunn, JM

机构：

[1] UNIV COLORADO,HLTH SCI CTR,DENVER,CO

[2] ROCKY MT INSTRUMENTAL LABS INC,FT COLLINS,CO

[3] VEREX LABS INC,ENGLEWOOD,CO

来源：

JOURNAL OF INVESTIGATIVE MEDICINE | 1996年 / 44卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：A250 / A250

页数：1

共 50 条

[1] ZIDOVUDINE PHARMACOKINETICS AND INTRALYMPHOCYTIC CONCENTRATIONS AFTER ADMINISTRATION OF CONVENTIONAL AND SUSTAINED-RELEASE PREPARATIONS
HOLLISTER, AS
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 55 (02) : 194 - 194
[2] THE EFFECTS OF A HIGH-FAT MEAL ON THE SERUM PHARMACOKINETICS OF SUSTAINED-RELEASE ZIDOVUDINE
HOLLISTER, AS
FRAZER, HA
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 55 (02) : 193 - 193
[3] Sustained-release zidovudine therapy reduces the frequency of resistance development in HIV-infected patients
Hollister, AS
Halverson, T
Dunn, JM
JOURNAL OF INVESTIGATIVE MEDICINE, 1996, 44 (03) : A249 - A249
[4] AZT (zidovudine) metabolism by human liver: Inhibition and activation of toxic metabolite formation in vitro
Inaba, T
Fayz, S
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 61 (02) : PI58 - PI58
[5] Bioavailability of a generic sustained-release formulation of diclofenac compared with the standard sustained-release formulation
Hooper, IT
Allen, E
McLaughlin, K
Ward, C
Sioufi, A
CLINICAL DRUG INVESTIGATION, 1996, 12 (05) : 259 - 270
[6] DIHYDROQUINIDINE METABOLITES OBSERVED AFTER ORAL-ADMINISTRATION OF A SUSTAINED-RELEASE FORMULATION IN MAN
FLOUVAT, B
RESPLANDY, G
ROUX, A
FRIOCOURT, P
VIEL, C
PLAT, M
THERAPIE, 1988, 43 (04): : 255 - 261
[7] SEVERE ANEMIA AFTER ZIDOVUDINE ADMINISTRATION
VALENCIA, ME
PINTADO, V
LAVILLA, P
AGUADO, AG
MEDICINA CLINICA, 1988, 90 (20): : 835 - 836
[8] FORMULATION OF TABLETS WITH SUSTAINED-RELEASE
SALOMON, JL
DOELKER, E
PHARMACEUTICA ACTA HELVETIAE, 1980, 55 (06): : 174 - 182
[9] Sustained-release zidovudine therapy reduces the frequency of resistance development in HIV-infected patients.
Hollister, AS
Halverson, T
Dunn, JM
JOURNAL OF INVESTIGATIVE MEDICINE, 1996, 44 (01) : A126 - A126
[10] PHARMACOKINETICS OF A SUSTAINED-RELEASE FORMULATION OF MELOXICAM AFTER SUBCUTANEOUS ADMINISTRATION TO AMERICAN FLAMINGOS (PHOENICOPTERUS RUBER)
Sim, Richard R.
Cox, Sherry K.
JOURNAL OF ZOO AND WILDLIFE MEDICINE, 2018, 49 (04) : 839 - 843

← 1 2 3 4 5 →